R9-6-201. Definitions

In this Article, unless otherwise specified: 1. “Clinical laboratory” has the same meaning as in A.R.S. § 36-451. 2. “Drug” has the same meaning as in A.R.S. § 32-1901. 3. “Epidemiologic curve” means a graphic display of the number of cases over time. 4. “Normally sterile site” means an anatomic location, or tissue or body fluid from an anatomic location, in which microorganisms are not found in the absence of disease and includes: a. The lower respiratory tract; b. Blood; c. Bone marrow; d. Cerebrospinal fluid; e. Pleural fluid; f. Peritoneal fluid; g. Synovial fluid; h. Pericardial fluid; i. Amniotic fluid; j. Lymph; k. A closed abscess; or l. Another anatomic location other than the skin, mouth, eyes, upper respiratory tract, middle ear, urogenital tract, or gastrointestinal tract. 5. “Health care provider required to report” means a physician, physician assistant, registered nurse practitioner, or dentist who diagnoses, treats, or detects a case or suspect case of a communicable disease listed in Table 2.1 or detects an occurrence listed in Table 2.1. 6. “Pharmacist” has the same meaning as in A.R.S. § 32- 1901. 7. “Point of contact” means an individual through whom the Department or a local health agency can obtain information upon request. 8. “Whole blood” means human blood from which plasma, erythrocytes, leukocytes, and thrombocytes have not been separated.